Milestone Payment. Within thirty (30) days following the first Patent Issuance, Eton shall give written notice to Imprimis and shall pay to Imprimis a non-refundable and noncreditable payment of fifty thousand dollars ($50,000).
Appears in 6 contracts
Sources: Asset Purchase and License Agreement (Eton Pharmaceuticals, Inc.), Asset Purchase and License Agreement (Eton Pharmaceuticals, Inc.), Asset Purchase and License Agreement (Eton Pharmaceuticals, Inc.)